All Access Fund
Partners Fund 2022

NeuroX1

About NeuroX1

NeuroX1 is developing a target ID and drug discovery platform leveraging proprietary generative AI algorithms to create the next generation of therapeutics for neurological disorders. Our early-stage pipeline consists of several pre-clinical assets partnered with a variety of pharma companies and institutions.


  • Artificial Intelligence
  • Big Data & Analytics
  • Cloud Software & Infrastructure
  • Deep & Frontier Tech